Ligand Pharmaceuticals, Inc. (NASDAQ:LGND)

CAPS Rating: 4 out of 5

Develops and markets new drugs that address critical unmet medical needs in the areas of cancer, mens and womens health, skin diseases, osteoporosis, and metabolic, cardiovascular and inflammatory diseases.

Recs

0
Player Avatar lowdti (31.94) Submitted: 12/26/2007 2:35:21 PM : Outperform Start Price: $32.88 LGND Score: -53.02

Nice

Featured Broker Partners


Advertisement